EGFR and glioblastoma: Multivariate analysis was performed on the GBM, IDH-WT cohort to evaluate other well-known factors such as gender, age, Chr +7/−10 (gain of chromosome 7 and loss of chromosome 10), EGFR amplification, TMZ treatment, and MGMT methylation.